Compare Jumia Technologies AG - ADR (JMIA) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jumia Technologies AG - ADR vs Medtronic PLC — how do they compare? Jumia Technologies AG - ADR trades at $6.35 (market cap $783.99M), while Medtronic PLC trades at $82.79 (market cap $106.61B). The key difference: Medtronic PLC is far larger — about 136× Jumia Technologies AG - ADR's market cap, and Medtronic PLC pays a 3.46% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals.
| JMIA | MDT | |
|---|---|---|
Market Cap | $783.99M | $106.61B |
Sector | Consumer Cyclical | Health |
52-Week High | $14.60 | $105.35 |
52-Week Low | $4.45 | $73.75 |
Enterprise Value | $731.09M | $125.36B |
Dividend Yield | — | 3.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
